13F filer · CIK 1747821
Decheng Capital Management III (Cayman), LLC
Grand Cayman, E9 · filing since Q1 2022 · last filing Dec 12, 2023
Reported value
$299.6M
$-19.2M vs prior
Positions
26
New / sold out
9 / 8
Added / reduced
1 / 2
Turnover
31.8%
buys $135.9M · sells $98.2M
Top-10 weight
79.2%
Biggest buys vs Q2 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | Alpine Immune Sciences, Inc. | +6,708,288 | – | +$76.8M |
| New | ROIVANT SCIENCES LTD | +1,459,700 | – | +$17.0M |
| Added | Aura Biosciences, Inc. | +869,790 | +296.5% | +$13.6M |
| New | LANTHEUS HOLDINGS INC(NMS) | +142,196 | – | +$9.9M |
| New | IMMUNOGEN INC | +415,880 | – | +$6.6M |
| New | SEAGEN INC | +23,014 | – | +$4.9M |
| New | BeyondSpring Inc. | +4,958,143 | – | +$4.0M |
| New | AtriCure Inc. | +46,259 | – | +$2.0M |
| New | Pyxis Oncology, Inc (formerly Apexigen) | +326,810 | – | +$650.4K |
| New | GeneDx Holdings Corp. | +103,604 | – | +$377.1K |
Biggest sells vs Q2 2023
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Alpine Immune Sciences, Inc. | -6,708,288 | -100.0% | $-69.0M |
| Sold out | ROIVANT SCIENCES LTD | -1,459,700 | -100.0% | $-14.7M |
| Sold out | BeyondSpring Inc. | -4,958,143 | -100.0% | $-5.9M |
| Sold out | Seagen Inc. | -23,014 | -100.0% | $-4.4M |
| Sold out | AtriCure Inc. | -46,259 | -100.0% | $-2.3M |
| Sold out | Apexigen, Inc. | -1,894,551 | -100.0% | $-814.3K |
| Sold out | GeneDx Holdings Corp. | -103,604 | -100.0% | $-617.5K |
| Reduced | Adicet Bio, Inc. | -305,467 | -60.4% | $-418.5K |
| Sold out | NeuBase Therapeutics, Inc. | -50,000 | -100.0% | $-92.5K |
| Reduced | ACELYRIN INC(NSM) | -6,100 | -0.4% | $-62.0K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2023
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Alpine Immune Sciences, Inc.COM | 6,708,288 | $76.8M | 25.63% |
| 2 | Zentalis Pharmaceuticals Inc.COM | 2,099,583 | $42.1M | 14.06% |
| 3 | Aura Biosciences, Inc.COM | 1,163,123 | $18.2M | 6.09% |
| 4 | ROIVANT SCIENCES LTDCOM | 1,459,700 | $17.0M | 5.69% |
| 5 | ACELYRIN INC(NSM)COM | 1,548,317 | $15.7M | 5.26% |
| 6 | Arcus Biosciences, IncCOM | 869,790 | $15.6M | 5.21% |
| 7 | 10x Genomics, Inc.CL A COM | 359,554 | $14.8M | 4.95% |
| 8 | Argenx SESHS | 27,429 | $13.5M | 4.50% |
| 9 | Pacific Biosciences of California, Inc.COM | 1,463,872 | $12.2M | 4.08% |
| 10 | Illumnia, Inc.COM | 80,859 | $11.1M | 3.70% |
16 more rows. Subscribe for $29/month to see every row, download the data and use the API.